COUGHLIN TIMOTHY

Average Profitability
11.55%
Insider Buys Quantity
1
Insider Buys Sum
$299,994.80
Insider Sells Quantity
33
Insider Sells Sum
$15.27M

Insider Activity of COUGHLIN TIMOTHY

The largest purchase of all time was on 2016-11-23 and amounted to 112780 shares of Fate Therapeutics, Inc. for $299,995.

The largest sale of all time was on 2015-06-08 and amounted to 60000 shares of Neurocrine Biosciences, Inc. for $2.7M.

Biography of COUGHLIN TIMOTHY

No biography is available at this moment.

2022-06-03SaleFate Therapeutics, Inc.
FATE
1,439
0.0014%
$22.81$32,824-19.37%
2017-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
963
0.0011%
$43.14$41,544+24.02%
2017-02-03SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,500
0.0017%
$42.55$63,825+23.74%
2017-01-17SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.002%
$40.65$71,138+31.5%
2017-01-10SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.002%
$43.37$75,898+23.56%
2016-11-23PurchaseFate Therapeutics, Inc.
FATE
director
112,780
0.245%
$2.66$299,995+11.55%
2016-02-03SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,500
0.0017%
$38.06$57,090+15.18%
2016-01-19SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.0021%
$46.69$81,708-0.89%
2016-01-11SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.002%
$44.25$77,438+2.78%
2015-10-16SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
25,000
0.0295%
$47.78$1.19M+0.15%
2015-07-20SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
20,000
0.0244%
$55.00$1.1M-11.04%
2015-07-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
20,000
0.0231%
$50.00$1M-7.41%
2015-06-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
60,000
0.0699%
$45.08$2.7M+3.67%
2015-03-20SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
40,000
0.0508%
$44.49$1.78M+5.73%
2015-01-16SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.0021%
$30.81$53,918+45.6%
2015-01-12SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
3,500
0.0042%
$28.37$99,295+54.85%
2015-01-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
20,000
0.0135%
$14.92$298,400+65.94%
2014-12-19SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
20,000
0.0258%
$24.02$480,400+78.28%
2014-12-18SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
40,000
0.0519%
$23.60$944,000+82.59%
2014-12-10SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
30,000
0.0288%
$16.02$480,700+98.77%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.